NEW YORK, NY / ACCESS Newswire / June 14, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:

You might also be interested in reading Cuban NFT artists say they face censorship within the crypto market.